MediWound’s NexoBrid receives TGA approval in Australia, enabling upcoming commercial launch and Asia-Pacific expansion.Quiver AI SummaryMediWound Ltd. has received marketing approval from Australia’s Therapeutic Goods Administration (TGA) for NexoBrid®, its enzymatic therapy for removing eschar in patients with deep partial- and full-thickness thermal burns, including children. This approval signifies that NexoBrid is now authorized in 45 countrRead More
